MDWD
MediWound Ltd.
$19.17
+$0.70(+3.79%)
48
Overall
--
Value
60
Tech
36
Quality
Market Cap
$207.82M
Volume
107.95K
52W Range
$14.14 - $22.51
Target Price
$31.50
Company Overview
| Mkt Cap | $207.82M | Price | $19.17 |
| Volume | 107.95K | Change | +3.79% |
| P/E Ratio | -6.9 | Open | $18.78 |
| Revenue | $20.0M | Prev Close | $18.47 |
| Net Income | $-30.2M | 52W Range | $14.14 - $22.51 |
| Div Yield | N/A | Target | $31.50 |
| Overall | 48 | Value | -- |
| Quality | 36 | Technical | 60 |
No chart data available
About MediWound Ltd.
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest News
Analysts’ Top Healthcare Picks: Elanco Animal Health (ELAN), Mediwound (MDWD)
Howard Kim•13 hours ago
Alliance Global Partners Reaffirms Their Buy Rating on Mediwound (MDWD)
TipRanks Auto-Generated Intelligence Newsdesk•17 days ago
Mediwound (MDWD) Receives a Buy from Oppenheimer
TipRanks Auto-Generated Intelligence Newsdesk•20 days ago
MediWound’s Q3 2025: Growth and Strategic Advances
TipRanks Auto-Generated Newsdesk•20 days ago
Analysts Are Bullish on Top Healthcare Stocks: Mediwound (MDWD), Exact Sciences (EXAS)
Howard Kim•21 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MDWD | $19.17 | +3.8% | 107.95K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |